Senator Grassley seeks info on Novartis’s Zolgensma data issues

>

Sharing is caring!

U.S. Senate Finance Committee Chairman Chuck Grassley has asked Swiss drugmaker Novartis AG to provide details on data manipulation related to its $2 million gene therapy, Zolgensma, by Aug. 23.

script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js">


Read More

Sharing is caring!

third ad

This site uses Akismet to reduce spam. Learn how your comment data is processed.